MRI Imaging Biomarkers for Prognostication of Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is a heterogeneous tumor with variable prognosis, even among patients at a similar tumor stage. Therefore, identifying prognostic features prior to treatment can help select the best therapeutic approach and ultimately optimize patient survival. While many imaging features on MRI have been suggested to have prognostic potential, some have emerged as critical imaging biomarkers, and efforts are underway to define and standardize relevant terminology. In this article, we comprehensively review MRI imaging features of HCC with prognostic potential.